Membrane processes for removal of pharmaceutically active compounds (PhACs) from water and wastewaters.

Pharmaceutically active compounds (PhACs), which find their way easily into the water sources, are emerging as a major concern for drinking water quality and aquatic species. Therefore, their removal from water sources is a priority from environmental point of view. During the past decade, different methods including membrane separation, adsorption systems and chemical transformation have been evaluated for removal of these compounds. This paper reviews different aspects of PhAC removal by using membrane separation processes, as they have been conventionally known to show high potential in the production of superior quality drinking and industrial water. In brief, osmosis membranes can efficiently remove almost all PhACs though its operational cost is relatively high and nanofiltration (NF) membranes are highly influenced by electrostatic and hydrophobic interaction. Moreover, the efficiency of membrane bioreactors (MBRs) is difficult to predict due to the complex interaction of compounds with microorganisms. To improve the performance and robustness of membrane technology, it is suggested to combine membranes with other systems, such as activated carbon and enzymatic degradation.

[1]  Robert C Andrews,et al.  The influence of natural organic matter and cations on the rejection of endocrine disrupting and pharmaceutically active compounds by nanofiltration. , 2009, Water research.

[2]  Zhi‐Kang Xu,et al.  Nanofibrous membranes containing reactive groups : Electrospinning from poly(acrylonitrile-co-maleic acid) for lipase immobilization , 2006 .

[3]  L. Nghiem,et al.  Removal of trace organic contaminants by an MBR comprising a mixed culture of bacteria and white-rot fungi. , 2013, Bioresource technology.

[4]  F. Elazhar,et al.  Techno-economic comparison of reverse osmosis and nanofiltration in desalination of a Moroccan brackish groundwater , 2015 .

[5]  Marta Carballa,et al.  How are pharmaceutical and personal care products (PPCPs) removed from urban wastewaters? , 2008 .

[6]  In S. Kim,et al.  Comparison of the removal efficiency of endocrine disrupting compounds in pilot scale sewage treatment processes. , 2008, Chemosphere.

[7]  Sven-Uwe Geissen,et al.  Elimination of carbamazepine in a non-sterile fungal bioreactor. , 2012, Bioresource technology.

[8]  Jiangyong Hu,et al.  Rejection of estrone by nanofiltration: Influence of solution chemistry , 2007 .

[9]  A. Schäfer,et al.  Removal of pharmaceuticals and endocrine disrupting compounds in a water recycling process using reverse osmosis systems , 2011 .

[10]  M. Petrovíc Analysis and removal of emerging contaminants in wastewater and drinking water , 2003 .

[11]  Zhi‐Kang Xu,et al.  Electrospun nanofibrous membranes filled with carbon nanotubes for redox enzyme immobilization , 2008 .

[12]  Menachem Elimelech,et al.  Impact of humic acid fouling on membrane performance and transport of pharmaceutically active compounds in forward osmosis. , 2013, Water Research.

[13]  A. Schäffer,et al.  Factors affecting the removal of organic micropollutants from wastewater in conventional treatment plants (CTP) and membrane bioreactors (MBR) , 2008 .

[14]  Long D. Nghiem,et al.  Rejection of pharmaceutically active compounds by forward osmosis: Role of solution pH and membrane orientation , 2012 .

[15]  Allan R. Chivas,et al.  Coupling effects of feed solution pH and ionic strength on the rejection of boron by NF/RO membranes , 2011 .

[16]  J. Cravedi,et al.  Removal of bisphenol A by a nanofiltration membrane in view of drinking water production. , 2006, Water research.

[17]  L. Nghiem,et al.  Removal of emerging trace organic contaminants by MBR-based hybrid treatment processes , 2013 .

[18]  G. Amy,et al.  Priority organic micropollutants in water sources in Flanders and the Netherlands and assessment of removal possibilities with nanofiltration. , 2007, Environmental pollution.

[19]  Rijul Dhingra,et al.  Forward Osmosis in India: Status and Comparison with Other Desalination Technologies , 2014, International scholarly research notices.

[20]  G. Amy,et al.  Rejection of pharmaceutically active compounds and endocrine disrupting compounds by clean and fouled nanofiltration membranes. , 2009, Water research.

[21]  C. Jolivalt Immobilization of laccase from Trametes versicolor on a modified PVDF microfiltration membrane: characterization of the grafted support and application in removing a phenylurea pesticide in wastewater , 2000 .

[22]  D. Barceló,et al.  Oxidation of atenolol, propranolol, carbamazepine and clofibric acid by a biological Fenton-like system mediated by the white-rot fungus Trametes versicolor. , 2010, Water research.

[23]  Shane A. Snyder,et al.  Removal of endocrine disrupting compounds and pharmaceuticals by nanofiltration and ultrafiltration membranes , 2007 .

[24]  L. Nghiem,et al.  Effects of membrane fouling on the nanofiltration of pharmaceutically active compounds (PhACs): Mechanisms and role of membrane pore size , 2007 .

[25]  Lubertus Bijlsma,et al.  Investigation of pharmaceuticals and illicit drugs in waters by liquid chromatography-high-resolution mass spectrometry , 2014 .

[26]  A. Krastanov,et al.  Biodegradation of phenols by laccase immobilised in a membrane reactor , 2000 .

[27]  Menachem Elimelech,et al.  Comparison of the removal of hydrophobic trace organic contaminants by forward osmosis and reverse osmosis. , 2012, Water research.

[28]  G. Feijoo,et al.  Laccase-catalyzed degradation of anti-inflammatories and estrogens , 2010 .

[29]  Jaeweon Cho,et al.  Evaluating controllability of pharmaceuticals and metabolites in biologically engineered processes, using corresponding octanol–water distribution coefficient , 2011 .

[30]  Menachem Elimelech,et al.  Pharmaceutical retention mechanisms by nanofiltration membranes. , 2005, Environmental science & technology.

[31]  Zhi‐Kang Xu,et al.  Covalent immobilization of lipase from Candida rugosa onto poly(acrylonitrile-co-2-hydroxyethyl methacrylate) electrospun fibrous membranes for potential bioreactor application. , 2008, Bioresource technology.

[32]  Jixiao Wang,et al.  Advanced treatment of a complex pharmaceutical wastewater by nanofiltration: Membrane foulant identification and cleaning , 2010 .

[33]  Menachem Elimelech,et al.  Energy requirements of ammonia-carbon dioxide forward osmosis desalination , 2007 .

[34]  Sven-Uwe Geissen,et al.  In vitro degradation of carbamazepine and diclofenac by crude lignin peroxidase. , 2010, Journal of hazardous materials.

[35]  T. Urase,et al.  Retention of a wide variety of organic pollutants by different nanofiltration/reverse osmosis membranes: controlling parameters of process , 2003 .

[36]  Craig D. Adams,et al.  Endocrine disrupting compounds removal from wastewater, a new challenge , 2006 .

[37]  Xitao Liu,et al.  Single-solute and bi-solute sorption of phenanthrene and dibutyl phthalate by plant- and manure-derived biochars. , 2014, The Science of the total environment.

[38]  Y. Laor,et al.  Using Dissolved Humic Acid To Remove Hydrophobic Contaminants from Water by Complexation−Flocculation Process , 1998 .

[39]  Jeill Oh,et al.  Adsorption of selected endocrine disrupting compounds and pharmaceuticals on activated biochars. , 2013, Journal of hazardous materials.

[40]  K. Kimura,et al.  Rejection of neutral endocrine disrupting compounds (EDCs) and pharmaceutical active compounds (PhACs) by RO membranes , 2004 .

[41]  Jonghun Han,et al.  Sonocatalytic-TiO2 nanotube, Fenton, and CCl4 reactions for enhanced oxidation, and their applications to acetaminophen and naproxen degradation , 2015 .

[42]  D. Barceló,et al.  Fate and removal of pharmaceuticals and illicit drugs in conventional and membrane bioreactor wastewater treatment plants and by riverbank filtration , 2009, Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences.

[43]  F. Naeimpoor,et al.  Effect of hydraulic retention time and temperature on submerged membrane bioreactor (SMBR) performance , 2012, Korean Journal of Chemical Engineering.

[44]  Ignasi Rodríguez-Roda,et al.  Comparison of removal of pharmaceuticals in MBR and activated sludge systems , 2010 .

[45]  H. Okamura,et al.  Elimination of carbamazepine by repeated treatment with laccase in the presence of 1-hydroxybenzotriazole. , 2010, Journal of hazardous materials.

[46]  G. Amy,et al.  A QSAR model for predicting rejection of emerging contaminants (pharmaceuticals, endocrine disruptors) by nanofiltration membranes. , 2010, Water research.

[47]  T. Poerio,et al.  Diclofenac Transport through Stagnant Sandwich and Supported Liquid Membrane Systems , 2006 .

[48]  S. Chellam,et al.  Simplified analysis of contaminant rejection during ground- and surface water nanofiltration under the information collection rule. , 2001, Water research.

[49]  Sangho Lee,et al.  A novel nanofiltration hybrid system to control organic micro-pollutants: application of dual functional adsorbent/catalyst , 2008 .

[50]  Huaidong Zhou,et al.  Sorption of phthalic acid esters in two kinds of landfill leachates by the carbonaceous sorbents. , 2013, Bioresource technology.

[51]  Wenshan Guo,et al.  The fate of pharmaceuticals, steroid hormones, phytoestrogens, UV-filters and pesticides during MBR treatment. , 2013, Bioresource technology.

[52]  Jiti Zhou,et al.  Factors affecting the membrane performance in submerged membrane bioreactors , 2006 .

[53]  C. Guizard,et al.  Mesoporous anatase coatings for coupling membrane separation and photocatalyzed reactions , 2005 .

[54]  Shane A. Snyder,et al.  Nanofiltration and ultrafiltration of endocrine disrupting compounds, pharmaceuticals and personal care products , 2006 .

[55]  Heleen De Wever,et al.  Comparison of sulfonated and other micropollutants removal in membrane bioreactor and conventional wastewater treatment. , 2007, Water research.

[56]  Damià Barceló,et al.  Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment. , 2009, Water research.

[57]  Fenglin Yang,et al.  Removal of trace antibiotics from wastewater: A systematic study of nanofiltration combined with ozone-based advanced oxidation processes , 2014 .

[58]  Young-Mo Kim,et al.  Enhanced transformation of triclosan by laccase in the presence of redox mediators. , 2010, Water research.

[59]  C. Vandecasteele,et al.  Influence of hydrophobicity on retention in nanofiltration of aqueous solutions containing organic compounds , 2005 .

[60]  A. Vukovic,et al.  Effect of water matrices on removal of veterinary pharmaceuticals by nanofiltration and reverse osmosis membranes. , 2011, Journal of environmental sciences.

[61]  Corinne Cabassud,et al.  Evaluation of membrane bioreactor on removal of pharmaceutical micropollutants: a review , 2015 .

[62]  A. Zimmerman,et al.  Adsorption of sulfamethoxazole on biochar and its impact on reclaimed water irrigation. , 2012, Journal of hazardous materials.

[63]  Jörg E. Drewes,et al.  Effects of membrane degradation on the removal of pharmaceutically active compounds (PhACs) by NF/RO filtration processes , 2009 .

[64]  Joseph R. V. Flora,et al.  Enhanced ultrasonic degradation of acetaminophen and naproxen in the presence of powdered activated carbon and biochar adsorbents , 2014 .

[65]  A. Bes-Piá,et al.  Reactive dyes rejection and textile effluent treatment study using ultrafiltration and nanofiltration processes , 2012 .

[66]  T. Heberer,et al.  Production of Drinking Water from Highly Contaminated Surface Waters: Removal of Organic, Inorganic, and Microbial Contaminants Applying Mobile Membrane Filtration Units , 2002 .

[67]  F. Omil,et al.  Fate of pharmaceuticals and cosmetic ingredients during the operation of a MBR treating sewage , 2008 .

[68]  S. Maeng,et al.  Influences of solid retention time, nitrification and microbial activity on the attenuation of pharmaceuticals and estrogens in membrane bioreactors. , 2013, Water research.

[69]  L. Nghiem,et al.  Mechanisms underlying the effects of membrane fouling on the nanofiltration of trace organic contaminants , 2010 .

[70]  Victor Yangali-Quintanilla,et al.  Rejection of micropollutants by clean and fouled forward osmosis membrane. , 2011, Water research.

[71]  H Kroiss,et al.  Removal of selected pharmaceuticals, fragrances and endocrine disrupting compounds in a membrane bioreactor and conventional wastewater treatment plants. , 2005, Water research.

[72]  Z. H. Li,et al.  Residual pharmaceutically active compounds (PhACs) in aquatic environment - status, toxicity and kinetics: a review. , 2018 .

[73]  Jinguo Kang,et al.  Removal of trace organic contaminants by a membrane bioreactor-granular activated carbon (MBR-GAC) system. , 2012, Bioresource technology.

[74]  Y. Hsieh,et al.  Immobilization of lipase enzyme in polyvinyl alcohol (PVA) nanofibrous membranes , 2008 .

[75]  K. Kimura,et al.  Adsorption of hydrophobic compounds onto NF/RO membranes: an artifact leading to overestimation of rejection , 2003 .

[76]  J. V. Dijk,et al.  Influence of membrane fouling by (pretreated) surface water on rejection of pharmaceutically active compounds (PhACs) by nanofiltration membranes , 2009 .

[77]  W. Leukes,et al.  Ultrafiltration of petrochemical industrial wastewater using immobilised manganese peroxidase and laccase: application in the defouling of polysulphone membranes☆ , 2002 .

[78]  Ze-hua Liu,et al.  Removal mechanisms for endocrine disrupting compounds (EDCs) in wastewater treatment - physical means, biodegradation, and chemical advanced oxidation: a review. , 2009, The Science of the total environment.

[79]  Kyung-Duk Zoh,et al.  Adsorption characteristics of selected hydrophilic and hydrophobic micropollutants in water using activated carbon. , 2014, Journal of hazardous materials.

[80]  Jaya Kandasamy,et al.  PHARMACEUTICAL WASTEWATER TREATMENT BY MEMBRANE BIOREACTOR PROCESS- A CASE STUDY IN SOUTHERN TAIWAN , 2008 .

[81]  M. Mauter,et al.  Emerging Pollutants – Part II: Treatment , 2012 .

[82]  M. I. Pariente,et al.  Coupling membrane separation and photocatalytic oxidation processes for the degradation of pharmaceutical pollutants. , 2013, Water research.

[83]  R. Tyagi,et al.  Removal of estrogenic activity of natural and synthetic hormones from a municipal wastewater: efficiency of horseradish peroxidase and laccase from Trametes versicolor. , 2008, Chemosphere.

[84]  Xiaoyan Yuan,et al.  Immobilization of cellulase in nanofibrous PVA membranes by electrospinning , 2005 .

[85]  T. Heberer Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data. , 2002, Toxicology letters.

[86]  Adriano Joss,et al.  Fate of sulfonamides, macrolides, and trimethoprim in different wastewater treatment technologies. , 2007, The Science of the total environment.

[87]  M. Moeder,et al.  Degradation of hydroxylated compounds using laccase and horseradish peroxidase immobilized on microporous polypropylene hollow fiber membranes , 2004 .

[88]  O. Kusakabe,et al.  Biodegradation characteristics of pharmaceutical substances by whole fungal culture Trametes versicolor and its laccase. , 2010 .

[89]  T. Urase,et al.  The effect of deterioration of nanofiltration membrane on retention of pharmaceuticals , 2007 .

[90]  Chuyang Y. Tang,et al.  Rejection of pharmaceuticals by forward osmosis membranes. , 2012, Journal of hazardous materials.

[91]  M. Ashokkumar,et al.  Combined advanced oxidation processes for the synergistic degradation of ibuprofen in aqueous environments. , 2010, Journal of hazardous materials.

[92]  S. Geissen,et al.  Carbamazepine and diclofenac: removal in wastewater treatment plants and occurrence in water bodies. , 2008, Chemosphere.

[93]  M. Elimelech,et al.  Role of electrostatic interactions in the retention of pharmaceutically active contaminants by a loose nanofiltration membrane , 2006 .

[94]  Long D Nghiem,et al.  Simultaneous activated carbon adsorption within a membrane bioreactor for an enhanced micropollutant removal. , 2011, Bioresource technology.

[95]  S. Sahebdelfar,et al.  Interaction effects in multicomponent separation by reverse osmosis , 2001 .

[96]  Sang-June Choi,et al.  The methods of identification, analysis, and removal of endocrine disrupting compounds (EDCs) in water. , 2009, Journal of hazardous materials.

[97]  K. Kimura,et al.  REJECTION OF ORGANIC MICROPOLLUTANTS (DISINFECTION BY-PRODUCTS, ENDOCRINE DISRUPTING COMPOUNDS, AND PHARMACEUTICALLY ACTIVE COMPOUNDS) BY NF/RO MEMBRANES , 2003 .

[98]  Long D. Nghiem,et al.  Removal of micropollutants by membrane bioreactor under temperature variation , 2011 .

[99]  A. López,et al.  Effective organics degradation from pharmaceutical wastewater by an integrated process including membrane bioreactor and ozonation. , 2010, Chemosphere.

[100]  J. Müller,et al.  Biodegradation of persistent polar pollutants in wastewater: comparison of an optimised lab-scale membrane bioreactor and activated sludge treatment. , 2006, Water research.

[101]  K. Ro,et al.  Sorption of bisphenol A, 17α-ethinyl estradiol and phenanthrene on thermally and hydrothermally produced biochars. , 2011, Bioresource technology.

[102]  Shane A. Snyder,et al.  Role of membranes and activated carbon in the removal of endocrine disruptors and pharmaceuticals , 2007 .

[103]  C. Purushothaman,et al.  Pharmaceutically Active Compounds (PhACs): A Threat for AquaticEnvironment? , 2013 .

[104]  L. Nghiem,et al.  Effects of chemical cleaning on the nanofiltration of pharmaceutically active compounds (PhACs) , 2012 .

[105]  Simon Judd,et al.  The cost of a large-scale hollow fibre MBR. , 2010, Water research.

[106]  D. Bagley,et al.  The rejection of endocrine disrupting and pharmaceutically active compounds by NF and RO membranes as a function of compound and water matrix properties , 2008 .

[107]  T. Vicent,et al.  Ability of white-rot fungi to remove selected pharmaceuticals and identification of degradation products of ibuprofen by Trametes versicolor. , 2009, Chemosphere.

[108]  Chung‐Hak Lee,et al.  Surface modification of nanofiltration membranes to improve the removal of organic micro-pollutants (EDCs and PhACs) in drinking water treatment: Graft polymerization and cross-linking followed by functional group substitution , 2008 .

[109]  Sangho Lee,et al.  A novel hybrid system for the removal of endocrine disrupting chemicals: Nanofiltration and homogeneous catalytic oxidation , 2008 .

[110]  Y. Hadar,et al.  Transformation of the recalcitrant pharmaceutical compound carbamazepine by Pleurotus ostreatus: role of cytochrome P450 monooxygenase and manganese peroxidase. , 2011, Environmental science & technology.

[111]  Long D. Nghiem,et al.  NF/RO filtration of the hydrophobic ionogenic compound triclosan : Transport mechanisms and the influence of membrane fouling , 2008 .

[112]  Helena Palmquist,et al.  Nanofiltration for the separation of pharmaceuticals from nutrients in source-separated urine. , 2006, Water research.

[113]  B. Bruggen,et al.  Removal of micropollutants during drinking water production from surface water with nanofiltration , 2006 .

[114]  Damia Barcelo,et al.  Degradation of carbamazepine by Trametes versicolor in an air pulsed fluidized bed bioreactor and identification of intermediates. , 2012, Water research.

[115]  Zhi‐Kang Xu,et al.  Nanofibrous poly(acrylonitrile-co-maleic acid) membranes functionalized with gelatin and chitosan for lipase immobilization. , 2006, Biomaterials.

[116]  F. Spina,et al.  Endocrine Disrupting Chemicals (edcs) in Municipal Wastewaters: Effective Degradation and Detoxification by Fungal Laccases , 2013 .

[117]  G. Esposito,et al.  Coupling of membrane filtration and advanced oxidation processes for removal of pharmaceutical residues: A critical review , 2015 .

[118]  Robert C. Andrews,et al.  Membrane adsorption of endocrine disrupting compounds and pharmaceutically active compounds , 2007 .

[119]  A. Ismail,et al.  A review of the effects of emerging contaminants in wastewater and options for their removal , 2009 .

[120]  Mira Petrovic,et al.  Analysis of pharmaceuticals in wastewater and removal using a membrane bioreactor , 2006, Analytical and bioanalytical chemistry.

[121]  L. Nghiem,et al.  Removal of bisphenol A and diclofenac by a novel fungal membrane bioreactor operated under non- sterile conditions , 2013 .

[122]  G. Feijoo,et al.  Enzymatic membrane reactors for biodegradation of recalcitrant compounds. Application to dye decolourisation. , 2002, Journal of biotechnology.

[123]  Ari Rabl,et al.  Uncertainty of air pollution cost estimates: to what extent does it matter? , 2005, Environmental science & technology.

[124]  Carlo Vandecasteele,et al.  Removal of pollutants from surface water and groundwater by nanofiltration: overview of possible applications in the drinking water industry. , 2003, Environmental pollution.

[125]  Stuart J. Khan,et al.  Effect of mixed liquor pH on the removal of trace organic contaminants in a membrane bioreactor. , 2010, Bioresource technology.

[126]  K. Kimura,et al.  Removal of pharmaceutical compounds by submerged membrane bioreactors (MBRs) , 2005 .

[127]  R. Moreira,et al.  Removal of pharmaceutical compounds in membrane bioreactors (MBR) applying submerged membranes , 2010 .

[128]  Samer Adham,et al.  Are membrane bioreactors ready for widespread application? , 2005, Environmental science & technology.

[129]  Yi‐nan Wu,et al.  The removal of bisphenol A from aqueous solutions by MIL-53(Al) and mesostructured MIL-53(Al). , 2013, Journal of colloid and interface science.

[130]  M. Yüksel,et al.  Removal of bisphenol A (BPA) from water by various nanofiltration (NF) and reverse osmosis (RO) membranes. , 2013, Journal of hazardous materials.

[131]  L. Mita,et al.  Non-isothermal bioremediation of waters polluted by phenol and some of its derivatives by laccase covalently immobilized on polypropylene membranes , 2010 .

[132]  Tzahi Y Cath,et al.  Removal of trace organic chemicals and performance of a novel hybrid ultrafiltration-osmotic membrane bioreactor. , 2014, Environmental science & technology.

[133]  S. Sakai,et al.  Immobilization of Pseudomonas cepacia lipase onto electrospun polyacrylonitrile fibers through physical adsorption and application to transesterification in nonaqueous solvent , 2010, Biotechnology Letters.

[134]  A. Seshasayee,et al.  Genomic Analysis Reveals Distinct Concentration-Dependent Evolutionary Trajectories for Antibiotic Resistance in Escherichia coli , 2014, DNA research : an international journal for rapid publication of reports on genes and genomes.

[135]  R. Tyagi,et al.  Laccase-catalyzed conversion of natural and synthetic hormones from a municipal wastewater. , 2007, Water research.

[136]  A. Schäfer,et al.  Sorption of micropollutant estrone to a water treatment ion exchange resin. , 2010, Journal of environmental monitoring : JEM.

[137]  Menachem Elimelech,et al.  Influence of membrane surface properties on initial rate of colloidal fouling of reverse osmosis and nanofiltration membranes , 2001 .

[138]  Long D. Nghiem,et al.  Combining MBR and NF/RO membrane filtration for the removal of trace organics in indirect potable wa , 2010 .

[139]  Santiago Esplugas,et al.  Ozonation and advanced oxidation technologies to remove endocrine disrupting chemicals (EDCs) and pharmaceuticals and personal care products (PPCPs) in water effluents. , 2007, Journal of hazardous materials.

[140]  Taro Urase,et al.  Factors affecting removal of pharmaceutical substances and estrogens in membrane separation bioreactors , 2005 .

[141]  A. Fane,et al.  Adsorption of trace steroid estrogens to hydrophobic hollow fibre membranes , 2002 .

[142]  Thorsten Reemtsma,et al.  Pathways and metabolites of microbial degradation of selected acidic pharmaceutical and their occurrence in municipal wastewater treated by a membrane bioreactor. , 2005, Water research.

[143]  C. Wisniewski,et al.  MEMBRANE BIOREACTOR FOR TREATMENT OF PHARMACEUTICAL WASTEWATER CONTAINING ACETAMINOPHEN , 2010 .

[144]  C. Dosoretz,et al.  Influence of seasonal and operating conditions on the rejection of pharmaceutical active compounds by RO and NF membranes , 2011 .

[145]  Yoshimasa Watanabe,et al.  Elimination of selected acidic pharmaceuticals from municipal wastewater by an activated sludge system and membrane bioreactors. , 2007, Environmental science & technology.

[146]  Mira Petrovic,et al.  Pharmaceuticals in Drinking Water , 2012 .

[147]  D. Barceló,et al.  Rejection of pharmaceuticals in nanofiltration and reverse osmosis membrane drinking water treatment. , 2008, Water research.

[148]  Richard M. Lueptow,et al.  Removal of organic contaminants by RO and NF membranes. , 2005, Journal of membrane science.

[149]  G. Feijoo,et al.  Oxidation of pharmaceutically active compounds by a ligninolytic fungal peroxidase , 2011, Biodegradation.

[150]  E R Cornelissen,et al.  Influence of electrostatic interactions on the rejection with NF and assessment of the removal efficiency during NF/GAC treatment of pharmaceutically active compounds in surface water. , 2007, Water research.